Trastuzumab, a recombinant monoclonal antibody, acts against HER2 receptors. Design: In this international randomized trial, women who had undergone surgical excision of a HER2-positive, early ...

By implementing the recently launched Blaze system, which uses a microchip-based icIEF separation with an on-chip ESI tip, and directly coupled to the SCIEX TripleTOF 6600 mass spectrometer, we will ...

Adjuvant trastuzumab emtansine (Kadcyla; T-DM1) showed higher rates of invasive-disease-free survival and overall survival as compared to trastuzumab (Herceptin) alone for patients with HER2-positive ...

At ASMS 2023, SCIEX, a global leader in life science analytical technologies, launches the Intabio ZT system, the first fully-integrated microfluidic chip-based platform combining imaged capillary ...

Trastuzumab biosimilar (Zercepac) and pertuzumab (Perjeta) combined with chemotherapy regimens showed efficacy among patients with HER2-positive breast cancer, according to a study published in the ...

Learn about the post-translational modifications that contribute to charge variants in protein therapeutics. Learn about the role of iCIEF and mass spectrometry and their relative impact on ...